Invivyd is a biopharmaceutical company focused on the discovery, development and commercialization of differentiated products for the prevention and/or treatment of viral infectious disease. Co. is obtaining regulatory authorization or approval for its lead product candidate, VYD222, for the prevention and/or treatment of SARS-CoV-2 (COVID-19). VYD222 is an engineered version of adintrevimab, Co.'s investigational monoclonal antibody. Co. is developing a pipeline of product candidates which could be used in prevention or treatment of serious viral diseases, starting with COVID-19 and expanding into influenza and other high-need indications. We show 7 historical shares outstanding datapoints in our IVVD shares outstanding history coverage, used to compute IVVD market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing IVVD market cap history over the course of time is important for investors
interested in comparing IVVD's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of IVVD versus a peer is one thing; comparing
IVVD market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like IVVD can fluctuate over the course of history.
With this page we aim to empower investors researching IVVD by allowing them to research the IVVD market cap history. |
Free IVVD Email Alerts:
Video: The Importance of Market Cap
